1. Home
  2. SILC vs BDSX Comparison

SILC vs BDSX Comparison

Compare SILC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicom Ltd

SILC

Silicom Ltd

HOLD

Current Price

$18.74

Market Cap

86.3M

Sector

Technology

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$11.33

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SILC
BDSX
Founded
1987
2005
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.3M
88.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SILC
BDSX
Price
$18.74
$11.33
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
81.2K
276.7K
Earning Date
01-29-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,926,000.00
$80,173,000.00
Revenue This Year
$17.17
$22.01
Revenue Next Year
$12.28
$26.81
P/E Ratio
N/A
N/A
Revenue Growth
6.56
22.29
52 Week Low
$12.44
$3.44
52 Week High
$23.00
$20.40

Technical Indicators

Market Signals
Indicator
SILC
BDSX
Relative Strength Index (RSI) 54.35 57.37
Support Level $18.55 $9.83
Resistance Level $21.22 $11.00
Average True Range (ATR) 1.86 1.13
MACD -0.07 -0.07
Stochastic Oscillator 46.48 69.05

Price Performance

Historical Comparison
SILC
BDSX

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: